학술논문

An ensemble learning-based machine learning with voting mechanism for chronic disease prediction
Document Type
Conference
Source
2024 International Conference on Artificial Intelligence, Computer, Data Sciences and Applications (ACDSA) Artificial Intelligence, Computer, Data Sciences and Applications (ACDSA), 2024 International Conference on. :1-6 Feb, 2024
Subject
Bioengineering
Communication, Networking and Broadcast Technologies
Components, Circuits, Devices and Systems
Computing and Processing
Engineered Materials, Dielectrics and Plasmas
Fields, Waves and Electromagnetics
General Topics for Engineers
Photonics and Electrooptics
Power, Energy and Industry Applications
Robotics and Control Systems
Signal Processing and Analysis
Heart
Measurement
Analytical models
Machine learning algorithms
Computational modeling
Decision making
Predictive models
Data models
Medical diagnostic imaging
Diseases
Ensemble Learning
Machine learning
Chronic Disease
Public Healthcare
Optimized learning
Language
Abstract
Chronic diseases present a significant challenge in healthcare, often requiring ongoing medical attention and posing limitations on patients' daily activities. Diagnosis of such diseases is hindered by the absence of specific symptoms making them hard to detect and or prevent. Addressing this issue, researchers have turned to computational approaches, analyzing patients' medical records to predict the presence or absence of chronic diseases with promising results. However, there is potential for further improvement. This paper introduces an ensemble classifier, ELVot-CroDiP, designed to enhance chronic disease prediction. ELVot-CroDiP harnesses the collective strengths of various machine learning algorithms through a majority voting mechanism, thereby boosting predictive accuracy. The model’s performance was evaluated using precision, recall, f1-score, and accuracy across five medical datasets, including heart disease, chronic kidney disease, diabetes, and heart stroke. Comparative analysis shows that ELVot-CroDiP offers superior performance in predicting chronic diseases compared to existing models, as evidenced by its higher scores in the mentioned evaluation metrics for each dataset tested.